StonvexLoading…
StonvexStonvexStonvexCore line items from OBIO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $33.48M | $2.64M | $2.76M | $3.53M |
Operating Income | $-51.81M | $-64.30M | $-51.51M | $-32.66M |
Net Income | $-52.70M | $-61.02M | $-49.12M | $-33.61M |
EPS (Diluted) | $-1.11 | $-1.66 | $-1.48 | $-2.24 |
Total Assets | $114.86M | $76.17M | $95.21M | $95.57M |
Total Liabilities | $51.48M | $43.22M | $27.17M | $43.04M |
Cash & Equivalents | $34.69M | $22.26M | $30.56M | $19.78M |
Free Cash Flow OCF − CapEx | $-49.45M | $-50.85M | $-46.20M | $-29.88M |
Shares Outstanding | 57.03M | 38.19M | 35.78M | 20.19M |